These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1158 related items for PubMed ID: 24805774
1. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D, Zhou Y. Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774 [Abstract] [Full Text] [Related]
2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B, Li J, Sun M, Sun L, Zhang X. IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [Abstract] [Full Text] [Related]
3. Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes. Li HL, Xie SP, Yang YL, Cheng YX, Zhang Y, Wang J, Wang Y, Liu DL, Chen ZF, Zhou YN, Wu HY. Asian Pac J Cancer Prev; 2015 May; 16(5):1781-7. PubMed ID: 25773825 [Abstract] [Full Text] [Related]
4. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu YP, Gui QJ, Zhang L, Li GQ. Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489 [Abstract] [Full Text] [Related]
5. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M. Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911 [Abstract] [Full Text] [Related]
6. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ. World J Gastroenterol; 2014 Dec 14; 20(46):17439-47. PubMed ID: 25516656 [Abstract] [Full Text] [Related]
7. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, Zhang WH, Yin LH, Pu YP. Clin Transl Oncol; 2017 Feb 14; 19(2):162-172. PubMed ID: 27173517 [Abstract] [Full Text] [Related]
8. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G. Oncol Rep; 2017 Jun 14; 37(6):3543-3553. PubMed ID: 28498428 [Abstract] [Full Text] [Related]
9. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach. Yan L, Jiao D, Hu H, Wang J, Tang X, Chen J, Chen Q. Exp Biol Med (Maywood); 2017 Apr 14; 242(7):709-717. PubMed ID: 28299977 [Abstract] [Full Text] [Related]
10. The correlation between miRNA and lymph node metastasis in gastric cancer. Huang KH, Lan YT, Fang WL, Chen JH, Lo SS, Li AF, Chiou SH, Wu CW, Shyr YM. Biomed Res Int; 2015 Apr 14; 2015():543163. PubMed ID: 25688358 [Abstract] [Full Text] [Related]
11. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer. Zhang J, Zhu Z, Sheng J, Yu Z, Yao B, Huang K, Zhou L, Qiu Z, Huang C. Oncotarget; 2017 May 23; 8(21):34867-34883. PubMed ID: 28432273 [Abstract] [Full Text] [Related]
12. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR. Cancer Genomics Proteomics; 2013 May 23; 10(3):93-113. PubMed ID: 23741026 [Abstract] [Full Text] [Related]
13. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H, Wang L, Zhou W, Zhang Z, Wang L, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X, Ge J. PLoS One; 2015 May 23; 10(5):e0125672. PubMed ID: 25938468 [Abstract] [Full Text] [Related]
14. Identification of microRNAs associated with lymphangiogenesis in human gastric cancer. Yang B, Jing C, Wang J, Guo X, Chen Y, Xu R, Peng L, Liu J, Li L. Clin Transl Oncol; 2014 Apr 23; 16(4):374-9. PubMed ID: 23881463 [Abstract] [Full Text] [Related]
15. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, Liu P. Cancer Chemother Pharmacol; 2013 May 23; 71(5):1159-71. PubMed ID: 23423488 [Abstract] [Full Text] [Related]
16. Clinical significance of miR-146a in gastric cancer cases. Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clin Cancer Res; 2011 Jul 01; 17(13):4277-84. PubMed ID: 21632853 [Abstract] [Full Text] [Related]
17. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer. Qin YZ, Xie XC, Liu HZ, Lai H, Qiu H, Ge LY. Oncol Rep; 2015 Jun 01; 33(6):2728-36. PubMed ID: 25845814 [Abstract] [Full Text] [Related]
18. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts]. Zeng Z, Hu P, Tang X, Zhang H, Du Y, Wen S, Liu M. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct 01; 30(10):1071-5. PubMed ID: 25270211 [Abstract] [Full Text] [Related]
19. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer. Li FQ, Xu B, Wu YJ, Yang ZL, Qian JJ. Genet Mol Res; 2015 Jan 30; 14(1):739-47. PubMed ID: 25730011 [Abstract] [Full Text] [Related]
20. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X. World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818 [Abstract] [Full Text] [Related] Page: [Next] [New Search]